Literature DB >> 12662431

Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy.

Elio Castagnola, Sandro Dallorso, Maura Faraci, Giuseppe Morreale, Daniela Di Martino, Emilio Cristina, Lucia Scarso, Edoardo Lanino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12662431     DOI： 10.1089/152581603321210082

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN： 1525-8165


× No keyword cloud information.
  6 in total

Review 1.  Does rituximab increase the incidence of infectious complications? A narrative review.

Authors:  Theodoros Kelesidis; George Daikos; Dimitrios Boumpas; Sotirios Tsiodras
Journal:  Int J Infect Dis       Date:  2010-11-11       Impact factor: 3.623

2.  Pneumocystis jirovecii pneumonia in two patients with systemic lupus erythematosus after rituximab therapy.

Authors:  F Bonilla-Abadía; J F Betancurt; J C Pineda; J D Vélez; G J Tobón; C A Cañas
Journal:  Clin Rheumatol       Date:  2014-01-09       Impact factor: 2.980

3.  Rituximab for steroid-refractory chronic graft-versus-host disease.

Authors:  Corey Cutler; David Miklos; Haesook T Kim; Nathaniel Treister; Sook-Bin Woo; Don Bienfang; Lloyd B Klickstein; Jesse Levin; Katherine Miller; Carol Reynolds; Rebecca Macdonell; Mildred Pasek; Stephanie J Lee; Vincent Ho; Robert Soiffer; Joseph H Antin; Jerome Ritz; Edwin Alyea
Journal:  Blood       Date:  2006-03-21       Impact factor: 22.113

Review 4.  Immunreconstitution and infectious complications after rituximab treatment in children and adolescents: what do we know and what can we learn from adults?

Authors:  Jennifer Worch; Olga Makarova; Birgit Burkhardt
Journal:  Cancers (Basel)       Date:  2015-01-29       Impact factor: 6.639

5.  Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases.

Authors:  Amer M Khojah; Michael L Miller; Marisa S Klein-Gitelman; Megan L Curran; Victoria Hans; Lauren M Pachman; Ramsay L Fuleihan
Journal:  Pediatr Rheumatol Online J       Date:  2019-08-28       Impact factor: 3.054

Review 6.  Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.

Authors:  Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.